Blue Horseshoe Report | Positive ID Corporation | PSID

Positive ID Corp. PSID

This morning we are talking about PSID, a stock which recently made a significant spike, and one that we are monitoring closely as it searches for a bottom. Before taking a look at the chart we’d like to briefly go over the various aspects of PSID‘s business, which we think you’ll find interesting.

Molecular Diagnostics:

Via its wholly-owned subsidiary acquired in 2011, MicroFluidic Systems (MFS), PSID develops sophisticated bio-threat detection systems for the purposes of rapid testing designed to detect a range of biological anomalies. Some of these medical diagnostic devices are reminiscent of something out of science fiction as you’ll see below, made possible through advanced molecular biotech.


The company’s M-BAND (Microfluidic Bio-agent Autonomous Networked Detector) threat detection system was developed under contract for the United States’ Department of Homeland Security, specifically to detect airborne pathogens (biological weapons), but the theoretical range of applications for this patented tech extends even further.

Its DragonFly system is a series of ‘microfluidic’ cartridges which can detect HPV, environmental bacteria, including antibiotic-resistant types such as MRSA. The DragonFly cartridges are low-cost, disposable, portable, and virtually fool-proof in their function. They facilitate testing with no worries over human error.

For point-of-care diagnosis, the FireFly Dx system is a portable handheld device capable of cell lysis, purification, PCR analysis, and the identification for nucleic acids, allowing for efficient field testing. PSID expects it to be of special significance for the third-world, where identification of potentially destructive pathogens is top priority for first-response teams, and an area which has been lacking in the past.

Diabetes Management:

Also under development, PSID has Easy Check, a glucose-level “breathalyzer”-type system that detects acetone levels in a diabetes patient’s breath, as an alternative to traditional pin-prick methods. Implementing single-use reagent capsules causing a chemical reaction allows detection of acetone which can be correlated to derive a glucose reading. The company reports preliminary testing at its Israeli research facility to have been successful, so we would be very excited for a future update on the progress of this aspect of PSID‘s business.

In the event that a workable and accurate device could be ultimately developed, it could chance the face of glucose testing for diabetics everywhere, a pool which includes a roughly-estimated 80 million adults in the US alone.

The company is reportedly working on yet another alternative to classic diabetes testing methods with an implantable RFID bio-sensor called the Glucochip.


PSID Chart:

As far as the PSID chart is concerned, if you take a look back to this past November, the stock ran from the low .02’s to almost .07 and spent the rest 2013 generally consolidating. At the end of last month the stock picked up once again, and last week ran to nearly .14, breaking that previous resistance point at .07. We’re now coming to PSID in the midst of another consolidation, with it posting three consecutive red candles to finish out last week.

We’ll want to keep a careful eye as this play searches out a bottom, because the opportunity for a significant bounce is present. We’ll need to see PSID hold support at or above .045 just below a recent gap on the chart. Once a rebound occurs, we will be on the lookout for a break of resistance at .07, which would certainly lead to a large percentage increase. Another run to its previous swing high from current levels would produce double-bag gains, so we’re placing PSID on intensive bottom-watch.


LINKS TO RECENT PRESS:


More Info @ PSID Website: http://www.positiveidcorp.com/


BMSN, NEWL, KNDI & Extended Watchlist

Bio-Matrix Scientific Group, Inc. BMSN
BMSN is an old-time favorite of ours, that we’ve most recently mentioned in both Friday and Monday‘s extended watchlists. On Friday, the stock was as low as .0032, which, at yesterday’s .0048 high, marked a two-session spike of 50% BMSN managed to get above the 200DMA, and broke above resistance at a recent swing high (05/06/13 @.0045). The next key resistance comes at .0062.

Side Note:
Also included in Friday’s report with BMSN was Entest Biomedical, Inc. (ENTB). The two companies are headed up by the same management team. After trading as low as .0019 yesterday, ENTB also made a run, closing at its high of .0026, a 37% move. We’ll be monitoring for a continuation of that momentum this morning.


NewLead Holdings Ltd. NEWL
Speaking of momentum plays, here’s one fresh off our morning scan: NEWL was rebounding off of a recent 52-week low and having a breakout session yesterday. The stock closed at its high of day, and even continued its ascent after-hours. We are going to want to watch this mover into today’s trading. Momentum like that often produces extended multi-day runs, and if that is the case here, we’ll want to take full advantage.


Kandi Technolgies Group, Inc. KNDI & Other EW Winners
We also wanted to give ourselves a hearty pat on the back for our timely inclusion of KNDI in yesterday’s Extended Watchlist. This NASDAQ-traded stock made quite an impressive daily run for a security in this its price-range, trading from a low of 7.20 up to 8.31, gaining 15% on the day.

Other gainers on the day from yesterday’s win-filled extended watchlist include OSH, IGLD, & RNN.


Extended Watchlist:
PSID, XIDE, FREE, STWG

PSID, MSTX & Extended Watchlist


PositiveID Corporation PSID
PSID continued to roll on Friday as we had indicated it might, turning in its second straight session where the it managed to close at or near its high of day. From Thursday’s open at .19 we never looked back, and as of Friday’s high of .29, we were looking at a two-day gain of 53%

Moving foward, we’d like to see PSID challenge and surpass its 50DMA of .33; if it can do that, we think there is a very good chance that this multi-day runner could continue to break out.

 

We also whipped up a quick rundown of the PSID chart in video format for your convenience:

For those that may have missed them: The company has been reaching out to the investment community via audio interviews recently as well. Lyle Probst, President of PSID subsidiary, Microfluidic Systems, appeared on SmallCap Voice on 06/04, and CEO William Caragol gave an exclusive interview on our sister site, StockTradersTalk.com.


Mast Therapeutics, Inc. MSTX
On Friday, we included MSTX in our extended watchlist, citing that it had been gapping down to 52-week lows, and that we wanted to put it on alert for a potential bounceplay. The stock seems to have established a base here, and we still have this one on watch, as that spike off of the bottom could be significant. We want to be ready and waiting to take advantage when it does.


Extended Watchlist:
ACYD, BMSN, KNDI, OSH, IGLD, RNN